Skip to main content
SpringerLink
Log in

Zwang und Störungen der Impulskontrolle

  • Chapter
Neurotransmitter und psychische Erkrankungen

Part of the book series: Tropon-Symposium VI ((BAYERZNS,volume 6))

Zusammenfassung

Zwangsphänomene sind wie Ängste und depressive Verstimmungen ubiquitäre Erscheinungen. Das gleiche gilt für andere, in ihrer Erscheinungsform teils unterschiedlich ausgestaltete impulshafte Handlungsweisen. Das pathologisch gesteigerte und schließlich mit subjektiver Beeinträchtigung und daraus resultierender sozialer Dysfunktion einhergehende Auftreten von Zwängen wird klinisch meist als Zwangsneurose bezeichnet. In den letzten Jahrzehnten sind zunächst Beiträge zur Zwangsneurose vorwiegend im epidemiologischen und therapeutischen Bereich—hier vornehmlich von Verhaltenstherapeuten — erfolgt. Zur Ätiopathogenese und hier insbesondere zu den biologischen Grundlagen dieser Störung gibt es erst in den letzten Jahren neue Arbeiten (Insel 1988; Rapoport u. Wise 1988, Stahl 1988, McDougle u. Goodman 1990).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Asberg M; Nordström P (1988) Biological correlates of suicidal behavior. In: Müller HJ, Schmidtke A, Welz R (eds) Current issues of suicidology. Springer, Berlin Heidelberg New York Tokyo, pp 223–241

    Google Scholar 

  • Asberg M, Träskman L, Thoren P (1976) 5-HIAA in the cerebrospinal fluid. Arch Gen Psychiatry 33:1193–1197

    Article  PubMed  CAS  Google Scholar 

  • Baxter LR, Thompson JM, Schwartz JM et al. (1987) Trazodone treatment response in obsessive-compulsive disorder-correlated with shifts in glucose metabolism in the caudate nuclei. Psychopathology 20 (suppl 1): 114–122

    Article  PubMed  Google Scholar 

  • Benkelfat C, Murphy DL, Zohar J, Hill JL, Grover G, Insel TR (1989) Clomipramine in obsessive-compulsive disorder. Arch Gen Psychiatry 46:23–28

    Article  PubMed  CAS  Google Scholar 

  • Brown CS, Kent TA, Bryant SG et al. (1989) Blood platelet uptake of serotonin in episodic aggression. Psychiatry Res 27:5–12

    Article  PubMed  CAS  Google Scholar 

  • Brown GL, Goodwin FK, Bellenger JD, Goyer PF, Major LF (1979) Aggression in humans correlates with cerebrospinal fluid metabolites. Psychiatry Res 1:131–139

    Article  PubMed  CAS  Google Scholar 

  • Brown GL, Ebert MH, Goyer PF, Jimerson DC, Klein WJ, Bunney WE, Goodwin FK (1982) Aggression, suicide and serotonin: relationships to CSF amine metabolites. Am J Psychiatry 139:741–746

    PubMed  CAS  Google Scholar 

  • Charney DS, Goodman WK, Price LH, Woods SW, Rasmussen SA, Heninger GR (1988) Serotonin function in obsessive-compulsive diesorder: a comparison of the effects to trytophan an m-chlorophenylpiperazine in patients and healthy subjects. Arch Gen Psychiatry 45:177–185

    Article  PubMed  CAS  Google Scholar 

  • Esquirol E (1838) Des maladies mentales considerees sous le rapport medical, hygienique et medicolegal. Balliere, Paris

    Google Scholar 

  • Flament MF, Rapoport JL, Berg CJ, Sceery W, Kilts C, Linnoila M (1985) Clomipramine treatment of childhood obsessive compulsive disorder: a double-blind controlles study. Arch Gen Psychiatry 42:977–983

    Article  PubMed  CAS  Google Scholar 

  • Flament MF, Rapoport JL, Murphy DL, Big CT, Lake CR (1987) Biochemical changes during clomipramine treatment of childhood obsessive-compulsive disorder. Arch Gen Psychiatry 44:219–225

    Article  PubMed  CAS  Google Scholar 

  • Foa EF, Steketee G, Kozak MJ, Dugger D (1987) Imipramine and placebo in the treatment of obsessive-compulsives: Their effect on depression and obsessional symptoms. Psychopharmacol Bull 23:8–11

    PubMed  CAS  Google Scholar 

  • Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, Charney DS (1989) Efficacy of fluovoxamine in obsessive-compulsive disorder: a double-blind comparison with placebo. Arch Gen Psychiatry 46:36–44

    Article  PubMed  CAS  Google Scholar 

  • Grimshaw L (1964) Obsessional disorder and neurological illness. J Neurol Neurosurg Psychiatry 27:229

    Article  PubMed  CAS  Google Scholar 

  • Hollander E, Fay M, Cohen B, Campeas J, Gorman JM, Liebowitz MR (1988) Serotonergic and noradrenergic sensitivity in obsessive compulsive disorder: behavioral findings. Am J Psychiatry 145:1015–1017

    PubMed  CAS  Google Scholar 

  • Hollander E, Schiffman E, Cohen B et al. (1990) Signs of central nervous system dysfunction in obsessive-compulsive disorder. Arch Gen Psychiatry 47:27–32

    Article  PubMed  CAS  Google Scholar 

  • Insel TR (1988) Obsessive-compulsive disorder: a neuroethological perspective. Psychopharmacol Bull 24:365–369

    PubMed  CAS  Google Scholar 

  • Janet P (1903) Les obsessions et la psychasthenie. Alcan, Paris

    Google Scholar 

  • Jaspers K (1909) Heimweh und Verbrechen. F.C.M. Vogel, Leipzig

    Google Scholar 

  • Jenike M, Baer M, Minichiello W (1990) Obsessive-compulsive disorders: theory and management. Year Book Med. Publ., Chicago

    Google Scholar 

  • Johnson FN (1984) The psychopharmacology of lithium. MacMillan, London

    Google Scholar 

  • Karno M, Golding I, Sorensen S, Burnham M (1988) The epidemiology of obsessive-compulsive disorder in five U.S. communities. Arch Gen Psychiatry 45:1094–1099

    Article  PubMed  CAS  Google Scholar 

  • Lesch KP, Hoh A, Müller T, Schulte HM, Osterheider M (1990a) 5-HT1A receptor responsitivity in obsessive-compulsive disorder. In: Proceedings 17th CINP, Vol 1. Kyoto, Japan, p 118

    Google Scholar 

  • Lesch KP, Mayer S, Hoh A et al. (1990b) 5-Hydroxytryptamine-1A (5-HT1a) receptor function in affective disorders. Pharmacopsychiatry 22:205

    Google Scholar 

  • Levine LR, Enas GG, Thompson WL (1989) Use of fluoxetine, a selective serotonin-uptake inhibitor, in the treatment of obesity: a dose-response study. Int J Obesity 13:635–645

    CAS  Google Scholar 

  • Lidberg L, Asberg M, Scalia-Tomba GP, Bertilsson L (1985) Homicide, suicide and CSF 5-HIAA. Acta Psychiatr Scand 71:230–236

    Article  PubMed  CAS  Google Scholar 

  • Lombroso C (1891) L’Uomo delinquente. Turin

    Google Scholar 

  • Lopez-Ibor JJ jr (1990) Impulsive control in obsessive-compulsive disorder: a biopsychopathological approach. Prog. Neuropsychopharmacol Biol Psychiatry 14:709–718

    Article  PubMed  Google Scholar 

  • Luxenberg JS, Swedo SE, Flament MF, Friedland RP, Rapoport JL, Rapoport SI (1988) Neuroanatomic abnormities in obsessive-compulsive disorder detected with quantitative x-ray computed tomography. Am J Psychiatry 145:1089–1094

    PubMed  CAS  Google Scholar 

  • Markovitz PJ, Stagno SJ, Calabrese JR (1990) Buspirone augmentation of fluoxetine in obsessive-compulsive disorder. Am J Psychiatry 147:798–800

    PubMed  CAS  Google Scholar 

  • Marks IM, Stern RS, Mawson D, Cobb J, McDonald R (1980) Clomipramine and exposure for obsessive compulsive rituals, I. Br J Psych 136:1–25

    Article  CAS  Google Scholar 

  • Mavissakalian M, Turner SM, Michalson L, Jacob R (1985) Tricyclic antidepressants in obsessive-compulsive disorder: Antiobsessional or antidepressant agents? II. Am J Psychiatry 142:572–576

    PubMed  CAS  Google Scholar 

  • McDougle CJ, Goodman WK (1990) Obsessive-compulsive disorder: recent neurobiological developments. Curr Opin Psychiatry 3:239–244

    Article  Google Scholar 

  • Meyendorff E, Jain A, Träskman-Bendz L, Stanley B, Stanley M (1986) The effects of fenfluramine on suicidal behavior. Psychopharmacol Bull 22:155–159

    PubMed  CAS  Google Scholar 

  • Miczek KA, DeBold JF (1983) Hormone-drug interactions and their influence on aggressive behavior. In: Svare BB (ed) Hormones and aggressive behavior. Plenum Press, New York, pp 313–347

    Google Scholar 

  • Miczek KA, Donat P (1989) Brain 5-HT systems and inhibition of aggressive behavior. In: Bevan P, Cool A, Archer T (eds) Bevioural pharmacology of 5-HT. Lawrence Erlbaum, Hillsdale, NJ, pp 117–144

    Google Scholar 

  • Miczek KA, Mos J, Olivier B (1989) Brain 5-HT and inhibition of aggressive behavior in animals: 5-HIAA and receptor subtypes. Psychopharmacol Bull 25:399–403

    PubMed  CAS  Google Scholar 

  • Montgomery SA (1980) Clomipramine in obsessional neurosis: A placebo controlled trial. Pharmacol Med 1:189–192

    Google Scholar 

  • Morand C, Young SN, Ervin FR (1983) Clinical response of aggressive schizophrenics to oral trypthophan. Biol Psychiatry 18:575–578

    PubMed  CAS  Google Scholar 

  • Mühlbauer HD (1985) Human aggression and the role of central serotonin. Pharmacopsychiatry 18:218–221

    Article  PubMed  Google Scholar 

  • Mühlbauer HD, Müller-Oerlinghausen B (1985) Fenfluramine stimulation of serum cortisol in patients with major affective disorders and healthy controls: Further evidence for a central serotonergic action of lithium in man. J Neural Transm 61:81–94

    Article  PubMed  Google Scholar 

  • Müller-Oerlinghausen B (1985) Lithium long term treatment. Does it act via serotonin? Pharmacopsychiatry 18:214–217

    Article  PubMed  Google Scholar 

  • Müller-Oerlinghausen B (1989) Pharmakotherapie pathologischen aggressiven und autoaggressiven Verhaltens. In: Pöldinger W, Wagner W (Hrsg) Aggression, Selbstaggression, Familie und Gesellschaft. Springer, Berlin Heidelberg New York Tokyo, s 121–134

    Google Scholar 

  • Olivier B, Mos J, Tulp M, Schipper J, Bevan P (1989) Modulatory action of serotonin in aggressive behavior. In: Bevan P, Cools A, Archer T (eds) Behavioural pharmacology of 5-HT. Lawrence Erlbaum, Hillsdale, NJ, pp 89–115

    Google Scholar 

  • Orzack MH, Friedman LM, Marby DW (1990) Weight changes on fluoxetine as a function of baseline weight in depressed outpatients. Psychopharmacol Bull 26:327–330

    PubMed  CAS  Google Scholar 

  • Osterheider M (1990) 5-HT receptors and anxiety. J Affective Disord 18 (Suppl):38–41

    Google Scholar 

  • Osterheider M (1991a) Neurological and psychometric findings in OCD. Psychiatry Res (in press)

    Google Scholar 

  • Osterheider M (1991b) Buspirone augmentation in fluoxetine treated OCD-patients. Pharmacopsychiatry (in press)

    Google Scholar 

  • Osterheider M, Lettmaier D (1991) Die Zwangserkrankung — Differentialdiagnose und Therapie. Nervenarzt (im Druck)

    Google Scholar 

  • Osterheider M, Lettmaier D, Beckmann H (1990) Basal ganglia disturbances in obsessive compulsive disorder. In: APA Proceedings, 143rd Animal Meeting. New Research Publ., New York, p 80

    Google Scholar 

  • Parent A, Poitras D, Dube L (1984) Comparative anatomy of central monoaminergic systems. In: Björklund A, Hökfelt T (eds) Handbook of chemical neuroanatomy, Vol 2: Classical transmitters in the CNS, Part I. Elsevier, Amsterdam, pp 409–439

    Google Scholar 

  • Peroutka SJ (1988) 5-Hydroxytryptamine receptor subtypes: Molecular, biochemical and physiological characterization. Trends Neurosci 11:496–500

    Article  PubMed  CAS  Google Scholar 

  • Perse TL, Greist JH, Jefferson JW, Rosenfeld R, Dar R (1988) Fluvoxamine treatment of obsessive-compulsive disorder. Am J Psychiatry 144:1543–1548

    Google Scholar 

  • Peters UH (1990) Wörterbuch der Psychiatrie und medizinischen Psychologie. Urban & Schwarzenberg, München

    Google Scholar 

  • Pucilowski O, Kostowski W (1983) Aggressive behavior and the central serotonergic system. Behav Brain Res 9:33–48

    Article  PubMed  CAS  Google Scholar 

  • Raleigh MJ, McGuire MT, Brammer GL, Yuwiler A (1984) Social and environmental influence on blood serotonin concentrations in monkeys. Arch Gen Psychiatry 41:405–410

    Article  PubMed  CAS  Google Scholar 

  • Rapoport JL (1989) The new biology of obsessive-compulsive disorder. Sci Am 260(3):82–89

    Article  PubMed  CAS  Google Scholar 

  • Rapoport JL (1991) Medikamentöse Behandlung der Zwangserkrankung. Nervenarzt 62:318–320

    PubMed  CAS  Google Scholar 

  • Rapoport JL, Wise SP (1988) Obsessive-compulsive disorder: evidence for basal ganglia dysfunction. Psychopharmacol Bull 24:380–384

    PubMed  CAS  Google Scholar 

  • Scott JP (1958) Aggression. The University of Chicago Press, Chicago

    Google Scholar 

  • Stahl SM (1988) Basal ganglia neuropharmacology and obsessive-compulsive disorder: The obsessive-compulsive disorder hypothesis of basal ganglia dysfunction. Psychopharmacol Bull 24:370–374

    PubMed  CAS  Google Scholar 

  • Swedo SE, Rapoport JL, Cheslow DL, Leonhard HL, Ayoub EM, Hosier DM, Wald ER (1989) High prevalence of obsessive-compulsive symptoms in patients with Sydenham’s chorea. Am J Psychiatry 146:2

    Google Scholar 

  • Thoren P, Asberg M, Cronholm B, Jornestedt L, Traskman L (1980) Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial. Arch Gen Psychiatry 37:1281–1285

    Article  PubMed  CAS  Google Scholar 

  • Virkkunen M, Nuutila A, Goodwin FK, Linnoila M (1987) CSF monoamine metabolites in male arsonists. Arch Gen Psychiatry 44:241–247

    Article  PubMed  CAS  Google Scholar 

  • Wakelin JS (1988) The role of serotonine in depression and suicide. Do serotonine reuptake inhibitors provide a key? Adv Biol Psychiatry 17:70–83

    Google Scholar 

  • Weilburg JB, Mesulam MM, Weintraub S, Buonanno F, Jenike M, Stakes JW (1989) Focal striatal abnormalities in a patient with obsessive-compulsive disorder. Arch Neurol 46:233–235

    Article  Google Scholar 

  • Westphal K (1878) über Zwangsvorstellungen. Arch Psychiatr Nervenkr 8:734–750

    Google Scholar 

  • Wickham EA, Reed JV (1987) Lithium for the control of aggressive and self-mutilating behavior. Int J Clin Psychopharmacol 2:181–190

    Article  CAS  Google Scholar 

  • Zohar J, Mueller EA, Insel TR, Zohar-Kadouch RC, Murphy DL (1987) Serotonergic responsitivity in obsessive-compulsive disorder: comparison of patients and healthy controls. Arch Gen Psychiatry 44:946–951

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. M. Osterheider
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Psychiatrische Klinik, Universät Würzburg, Füchleinstr. 15, Würzburg, W-8700, Deutschland

    Helmut Beckmann  & Michael Osterheider  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Osterheider, M. (1991). Zwang und Störungen der Impulskontrolle. In: Beckmann, H., Osterheider, M. (eds) Neurotransmitter und psychische Erkrankungen. Tropon-Symposium VI, vol 6. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84544-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-84544-4_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-54220-9

  • Online ISBN: 978-3-642-84544-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation